Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Joubert

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Plos One|August 29, 2015
Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal InsufficiencyElise Rousseau, Michael Joubert, Géraldine Trzepla, et al.
BMJ Open|January 8, 2025
Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort studyRamzi A Ajjan, Tadej Battelino, J Seufert, et al.
Journal of Diabetes Science and Technology|March 12, 2025
Performance of an Automated Insulin Delivery System in People Living With Type 2 Diabetes and Insulin Resistance: First Real-World Evidence in 26 427 UsersIsabeau Thijs, Arcelia Arrieta, Javier Castañeda, et al.
Diabetes, Obesity & Metabolism|December 22, 2025
Comparative accuracy of smartphone apps and a generative AI tool for carbohydrate counting: An independent bicentric studyMichael Joubert, Bleuenn Dreves, Theo Arnould, et al.
Cardiovascular Diabetology|January 9, 2024
Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims databasePatrick Blin, Michael Joubert, Patrick Jourdain, et al.
Diabetes|January 6, 2017
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse ModelMichael Joubert, Benoît Jagu, David Montaigne, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 17, 2024
Advanced Hybrid Closed Loop Algorithm Use in Type 1 Diabetes: The French MiniMed™ Glycemic Control and Quality of Life StudyLaurence Kessler, Charles Thivolet, Alfred Penfornis, et al.
Diabetes, Obesity & Metabolism|June 8, 2019
Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab-2 randomized controlled trialSylvia Franc, Michael Joubert, Ahmed Daoudi, et al.
Journal of Diabetes Science and Technology|March 14, 2019
Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care ProvidersMichael Joubert, Pierre-Yves Benhamou, Pauline Schaepelynck, et al.
Diabetes Technology & Therapeutics|January 18, 2024
12-Month Real-Life Efficacy of the MiniMed 780G Advanced Closed-Loop System in Patients Living with Type 1 Diabetes: A French Observational, Retrospective, Multicentric StudySandrine Lablanche, Johanna Delagenière, Manon Jalbert, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Plos One|August 29, 2015
Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal InsufficiencyElise Rousseau, Michael Joubert, Géraldine Trzepla, et al.
BMJ Open|January 8, 2025
Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort studyRamzi A Ajjan, Tadej Battelino, J Seufert, et al.
Journal of Diabetes Science and Technology|March 12, 2025
Performance of an Automated Insulin Delivery System in People Living With Type 2 Diabetes and Insulin Resistance: First Real-World Evidence in 26 427 UsersIsabeau Thijs, Arcelia Arrieta, Javier Castañeda, et al.
Diabetes, Obesity & Metabolism|December 22, 2025
Comparative accuracy of smartphone apps and a generative AI tool for carbohydrate counting: An independent bicentric studyMichael Joubert, Bleuenn Dreves, Theo Arnould, et al.
Cardiovascular Diabetology|January 9, 2024
Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims databasePatrick Blin, Michael Joubert, Patrick Jourdain, et al.
Diabetes|January 6, 2017
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse ModelMichael Joubert, Benoît Jagu, David Montaigne, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 17, 2024
Advanced Hybrid Closed Loop Algorithm Use in Type 1 Diabetes: The French MiniMed™ Glycemic Control and Quality of Life StudyLaurence Kessler, Charles Thivolet, Alfred Penfornis, et al.
Diabetes, Obesity & Metabolism|June 8, 2019
Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab-2 randomized controlled trialSylvia Franc, Michael Joubert, Ahmed Daoudi, et al.
Journal of Diabetes Science and Technology|March 14, 2019
Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care ProvidersMichael Joubert, Pierre-Yves Benhamou, Pauline Schaepelynck, et al.
Diabetes Technology & Therapeutics|January 18, 2024
12-Month Real-Life Efficacy of the MiniMed 780G Advanced Closed-Loop System in Patients Living with Type 1 Diabetes: A French Observational, Retrospective, Multicentric StudySandrine Lablanche, Johanna Delagenière, Manon Jalbert, et al.
Pageof 8